Sunitinib combination reduces PSA levels in metastatic HRPC: Commentary
Publication
, Other
Moul, JW
Published in: Oncology Report
September 1, 2008
Duke Scholars
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2008
Issue
FALL
Start / End Page
39
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W. (2008). Sunitinib combination reduces PSA levels in metastatic HRPC: Commentary. Oncology Report.
Moul, J. W. “Sunitinib combination reduces PSA levels in metastatic HRPC: Commentary.” Oncology Report, September 1, 2008.
Moul JW. Sunitinib combination reduces PSA levels in metastatic HRPC: Commentary. Oncology Report. 2008. p. 39.
Moul, J. W. “Sunitinib combination reduces PSA levels in metastatic HRPC: Commentary.” Oncology Report, no. FALL, 1 Sept. 2008, p. 39.
Moul JW. Sunitinib combination reduces PSA levels in metastatic HRPC: Commentary. Oncology Report. 2008. p. 39.
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2008
Issue
FALL
Start / End Page
39
Related Subject Headings
- Oncology & Carcinogenesis